Xeltis

Lifelet Medical

Lifelet Medical develops synthetic polymer heart valve replacements for patients with heart valve disease to replace animal-tissue-based solutions.

STENTiT

The company develops biodegradable endovascular implants that promote vascular tissue regeneration to treat patients suffering from cardiovascular diseases like peripheral artery disease.

Xenerate AB

This company developed gene-technology-based vascular devices, such as stents and grafts, to improve biocompatibility for patients undergoing cardiovascular procedures.

Healionics

Healionics produces synthetic vascular grafts for dialysis patients to improve blood access and reduce complications such as infection and occlusion.

Aortyx

This company develops bioresorbable endovascular patches and catheter delivery systems for surgeons to treat patients with aortic dissection and other vascular diseases.

CuroTis

This biotechnology company develops regenerative grafts that stimulate the body to grow patient-specific blood vessels for individuals requiring vascular access or organ regeneration.

Artifex

This company develops artificial vascular grafts for patients undergoing coronary and peripheral bypass surgery.

XS Innovations

This company develops implantable vascular access valves for patients with end-stage kidney disease to reduce complications during and between haemodialysis sessions.